Ignite Creation Date:
2024-05-06 @ 3:16 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04577703
Status:
COMPLETED
Last Update Posted:
2020-10-08
First Post:
2020-09-16
Brief Title:
First-In-Human Phase I Trial of Ningetinib CT053PTSA in the Patients With Advanced Solid Tumors
Sponsor:
Organization:
Sunshine Lake Pharma Co Ltd